Poland vs Tanzania: The number of people with susceptibility test result for rifampicin
Poland
91.55
in 2021
Tanzania
90.17
in 2021
Poland rank
65th
Tanzania rank
67th
The number of people with susceptibility test result for rifampicin over time
- Poland
- Tanzania
How they compare
Poland currently reports 91.55 against 90.17 in Tanzania, a difference of 1.38.
Across all 5 years both countries report, Poland has been ahead every year.
Poland ranks 65th and Tanzania ranks 67th of 146 countries.
Poland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Poland | Tanzania | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 89.97 | 61.78 | 28.19 | Poland |
| 2020s | 90.9 | 77.55 | 13.35 | Poland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Poland or Tanzania?
- Poland, at 91.55 against 90.17 in Tanzania as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Poland and Tanzania?
- 1.38, with Poland ahead.
- How many years of comparable data are there for Poland and Tanzania?
- 5 years are reported by both, from 2017 to 2021.
- How do Poland and Tanzania rank globally for the number of people with susceptibility test result for rifampicin?
- Poland ranks 65th and Tanzania ranks 67th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.